Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Clinical trial NCT02914600 · TERMINATED
Trial details
- NCT number
- NCT02914600
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-17
- Primary completion
- 2023-08-01
- Enrollment
- 1188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.